Sharda Cropchem Limited has received a credit rating reaffirmation from Crisil Limited, maintaining its strong financial standing in the agrochemical sector. The company announced this development to stock exchanges on February 23, 2026, highlighting the continued confidence of the rating agency in its creditworthiness.

Credit Rating Details

Crisil Limited has reaffirmed Sharda Cropchem Limited's short-term credit rating at 'Crisil A1+' for bank facilities worth Rs. 456 crores. This reaffirmation demonstrates the rating agency's assessment of the company's strong ability to meet its short-term financial obligations and maintain liquidity.

Regulatory Compliance

The announcement was made in accordance with Regulation 30(6) read with Schedule III of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. This regulatory framework requires listed companies to promptly disclose material information, including credit rating actions, to ensure transparency for investors and stakeholders.

Rating Significance

The 'Crisil A1+' rating represents the highest level of safety regarding timely payment of financial obligations and carries the lowest credit risk in the short-term rating category. This reaffirmation indicates that Crisil Limited continues to view Sharda Cropchem Limited as having strong financial fundamentals and operational capabilities.

The detailed ratings rationale has been made available on Crisil Limited's official website, providing comprehensive insights into the factors considered during the rating assessment. This transparency allows stakeholders to understand the basis for the rating decision and the company's financial position.

Market Communication

The communication was signed by Jetkin Gudhka, Company Secretary and Compliance Officer of Sharda Cropchem Limited, and was addressed to both the National Stock Exchange of India Limited and BSE Limited. The company trades under the symbol 'SHARDACROP' on NSE and scrip code '538666' on BSE, ensuring broad market visibility of this positive development.

Sharda Cropchem Limited disclosed the transcript of its Q3FY26 earnings conference call conducted on January 30, 2026, providing detailed insights into the company's exceptional financial performance and future growth prospects. The management team, led by Chairman and Managing Director R.V. Bubna, discussed the robust quarterly results and strategic outlook during the analyst interaction.

Earnings Call Disclosure Details

The company filed the earnings call transcript under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, on February 3, 2026. The conference call was conducted through digital means at 1:00 PM IST on January 30, 2026, with participation from key management personnel.

Management Commentary on Q3FY26 Performance

During the earnings call, Chairman R.V. Bubna highlighted the company's achievement of highest-ever PAT for any year, driven by strong volume growth and improved product mix. The management emphasized that despite Q4 being traditionally the strongest quarter, the growth momentum is expected to continue through Q4 FY26 and remain robust in FY27.

Key Performance Metrics Discussed:

• Total revenue growth of 39% to ₹1,289 crores
• Overall volume growth of 14%
• Gross margin expansion of 220 basis points to 34.9%
• EBITDA growth of 59% to ₹246 crores with 19.1% margins
• PAT growth of 366% to ₹145 crores

Revenue Growth Composition Analysis

CFO Shailesh Mehendale provided detailed breakdown of the revenue growth drivers during the analyst interaction, offering transparency into the company's performance metrics.

Geographic Performance Insights

The management discussed regional performance variations, with Europe showing exceptional growth while NAFTA region experienced some decline. Bubna attributed Europe's strong performance to favorable climate conditions, good agricultural demand, and the company's ability to meet customer requirements on time.

Gross Margin by Geography (Q3FY26):

• Europe: 43.0%
• NAFTA: 23.5%
• LATAM: 29.2%
• Rest of World: 37.0%
• Overall Agrochemicals: 35.9%

Product Registration Portfolio Update

The earnings call revealed updated registration statistics, demonstrating the company's continued investment in expanding its global market access through comprehensive product registrations.

Forward-Looking Guidance and Outlook

Management provided positive guidance for FY27, expecting 15% volume growth and revenue growth of 15-20%. The company maintained its EBITDA margin guidance of 18-20% for both FY26 and FY27, with gross margins expected to remain sustainable around 35% levels. Planned capex for FY27 is projected in the range of ₹450-500 crores, supporting continued growth initiatives.

The management emphasized that agrochemical products remain unaffected by tariff concerns due to their registration-dependent nature, providing stability in the business model. With cash and liquid investments of ₹826 crores as of December 31, 2025, the company maintains a strong financial position while exploring opportunities for increased dividend payouts.